Today: 25 April 2026
Amazon stock price today: AMZN dips as investors weigh AWS AI content plan and pharmacy delivery expansion
11 February 2026
1 min read

Amazon stock price today: AMZN dips as investors weigh AWS AI content plan and pharmacy delivery expansion

NEW YORK, February 11, 2026, 10:01 EST — Regular session

Amazon.com, Inc. (AMZN) dropped 0.7% to $205.43 in Wednesday morning action. Shares hovered near session lows after an early move just over $209.

The retreat follows a notable surge from retail investors, who piled in during the latest dip. On Friday, Amazon saw its largest one-day net retail buying since August 2024, Vanda Research told Reuters.

But those purchases haven’t put the bigger question to rest: just how much cash Amazon will need to spend before AI demand starts making a clear impact on earnings. Last week, Amazon put investors on notice with plans for roughly $200 billion in capital expenditures—money earmarked for things like data centers and chips—in 2026. That revelation sent the stock lower. “The market just dislikes the substantial amount of money that keeps getting put into capex for these growth rates,” said Dave Wagner, portfolio manager at Aptus Capital Advisors. Reuters

Reuters, referencing The Information, said Tuesday that Amazon Web Services has floated the idea of a marketplace letting publishers sell content to AI product makers. According to the report, AWS presentation slides, prepared for a publisher event, pitched the concept of a content marketplace alongside Bedrock and Quick Suite, its main AI offerings. Amazon’s spokesperson told Reuters there’s “nothing specific to share.” Reuters

Amazon flagged another push into healthcare logistics, saying its pharmacy arm will roll out same-day prescription delivery to roughly 4,500 U.S. cities and towns this year—nearly 2,000 more communities getting access. The move follows Amazon’s 2018 PillPack acquisition, an October partnership with WeightWatchers targeting delivery of prescriptions like injectable GLP-1 obesity drugs, and December’s launch of prescription kiosks at One Medical clinics.

Stocks found some footing as the SPDR S&P 500 ETF added 0.5%. QQQ, which tracks the Nasdaq, was up around 0.7%. Microsoft slipped close to 1%, and Alphabet was also down, but just slightly.

Still, the core question about Amazon’s multiple isn’t answered by the AI marketplace or pharmacy push. These ventures might need a while before they really deliver reliable revenue. If Amazon gets spending wrong — say, building out too much too soon — that’s going to hit margins before any growth materializes.

The rates backdrop has rattled big tech stocks this month, and traders aren’t losing sight of it. Friday’s U.S. January consumer price numbers hit at 8:30 a.m. ET—a drop that could jolt rate expectations again.

Next up: the Federal Reserve releases minutes from its Jan. 27-28 meeting on Feb. 18. Amazon’s situation adds another layer—investors are pushing to see if the publisher-content marketplace becomes more than just talk and presentations, and if it does, who actually calls the shots on pricing.

Stock Market Today

  • AstraZeneca Share Price Pullback: Attractive Buy or Overvalued?
    April 25, 2026, 1:29 PM EDT. AstraZeneca (LSE:AZN) shares dropped 7.7% in the past week, closing at £139.56. Despite this, it's gained 36.5% over the past year. A discounted cash flow (DCF) analysis values AstraZeneca at around US$237.83 per share, implying the stock trades at a 41.3% discount to intrinsic value, suggesting it is undervalued. The company's free cash flow is projected to rise from US$9.49 billion to US$20.18 billion by 2030. Market sentiment is influenced by its pharmaceutical pipeline and regulatory developments. AstraZeneca's price-to-earnings (P/E) ratio remains a key metric for evaluating growth expectations. Investors should weigh recent declines against long-term fundamentals and risks to determine potential value in the stock.

Latest article

Uranium Energy Corp Stock Slides 6% as New U.S. Uranium Mine Becomes the Real Test

Uranium Energy Corp Stock Slides 6% as New U.S. Uranium Mine Becomes the Real Test

25 April 2026
Uranium Energy Corp. shares fell 6% to $14.05 Friday as uranium stocks retreated, despite the company starting production at its Burke Hollow mine in Texas earlier this month. Energy Fuels, Cameco, and NexGen Energy also declined. UEC reported $20.2 million in uranium sales last quarter and ended with $818 million in liquid assets and no debt. The company is expanding operations in Texas and Wyoming.
US Stock Market This Week: S&P 500, Nasdaq Hit Records as Intel Sparks AI Rally

US Stock Market This Week: S&P 500, Nasdaq Hit Records as Intel Sparks AI Rally

25 April 2026
The S&P 500 and Nasdaq closed at record highs Friday, lifted by a surge in chip stocks after Intel’s strong forecast. The Dow slipped 0.16%. Intel’s revenue and outlook beat estimates, sending its shares and peers like AMD and Nvidia sharply higher. IBM and ServiceNow weighed on software stocks, highlighting uneven performance across sectors.
Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

25 April 2026
SiriusXM is in early merger talks with iHeartMedia, Bloomberg reported Friday, potentially combining the largest U.S. satellite-radio and broadcast-radio companies. SiriusXM shares fell nearly 5% while iHeartMedia surged 35% on deal speculation. Both firms declined to comment. SiriusXM reports first-quarter results April 30, with investors watching subscriber and ad trends.
Accenture stock drops as CEO share-sale filing and $1.4 billion contract protest hit tape
Previous Story

Accenture stock drops as CEO share-sale filing and $1.4 billion contract protest hit tape

Brent crude price jumps near $70 as Iran risk lifts oil despite big U.S. stock build
Next Story

Brent crude price jumps near $70 as Iran risk lifts oil despite big U.S. stock build

Go toTop